Back to Results
First PageMeta Content
Research / Pharmacology / National Institutes of Health / Pharmaceutical industry / Pharmacy / Division of Signal Transduction Therapy / AstraZeneca / Translational medicine / Translational research / Medicine / Health / Medical research


Partnering for success: scientific, business & economic development Chris Yochim, Global Head of External Relations Global Product and Portfolio Strategy (GPPS)
Add to Reading List

Document Date: 2014-06-10 13:17:28

Open Document

File Size: 920,57 KB

Share Result on Facebook

Company

Eli Lilly / Pfizer / GlaxoSmithKline / Bayer / Abbott / In 2009 AstraZeneca Cardio-Vascular & Metabolism Group / Sanofi / Vertex Pharmaceuticals Inc. / Boehringer Ingelheim / Merck Serono / AstraZeneca / Janssen Pharmaceuticals / /

Country

United States / /

Currency

USD / GBP / /

Event

Product Issues / Person Communication and Meetings / FDA Phase / /

Facility

University of Virginia / Texas A&M University / The University of Dundee / University of Dundee / clinic e.g. / Weill Cornell Medical College / /

IndustryTerm

protein product / pharmaceutical / imaging / /

MedicalCondition

Diabetic Nephropathy / TB / cancer / disease / tumour / cardiovascular disease / Diabetes / heart failure / Abdominal Aortic Aneurysm / Cystic Fibrosis / inflammation / inflammatory diseases / tuberculosis / /

Organization

Melinda Gates Foundation / University of Virginia / National Institute of Health / Division of Signal Transduction Therapy / FDA / Cystic Fibrosis Foundation / Texas A&M University / Weill Cornell Medical College / NHS / University of Dundee / /

Person

Chris Yochim / /

Position

Global Head of External Relations Global Product / Scientist / /

Product

Kalydeco / Iressa / CFTR / protein product / gene / TB Drug / /

ProvinceOrState

Virginia / Arizona / /

Technology

drug delivery / cell signaling / drug development / /

SocialTag